DrugPatentWatch Database Preview
Barr Labs Inc Company Profile
What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?
BARR LABS INC has seventeen approved drugs.
There are three tentative approvals on BARR LABS INC drugs.
Summary for Barr Labs Inc
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 15 |
| NDAs: | 17 |
Drugs and US Patents for Barr Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr Labs Inc | TRI LO SPRINTEC | ethinyl estradiol; norgestimate | TABLET;ORAL-28 | 076784-001 | Jun 29, 2009 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Barr Labs Inc | GLIPIZIDE | glipizide | TABLET;ORAL | 074619-001 | Apr 4, 1997 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Barr Labs Inc | MINOCYCLINE HYDROCHLORIDE | minocycline hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 065485-004 | May 18, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
